GNTAGenenta Science S.p.A.

GNTA Stock Price, Valuation & Chart | Genenta Science S.p.A.

Compare

$0.980-0.03 (-3.16%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology GNTA intrinsic value GNTA calculated fair value vs price

Overview Financials Dividends Ratios

GNTA Historical price chart

GNTA Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization18.73M

PE Ratio-1.34

EPS-0.73

Trading Volume23.32K

Today's High/Low1.0/0.97

Dividend Yield0.00

52 Week High/Low10.0/0.55

Shares Outstanding19.15M

GNTA Financial Statement

GNTA Analyst ratings

GNTA Analysis & performance metrics

GNTA Company profile

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in…

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is also developing…

GNTA Management team

Name

Position

Carlo Russo M.D.

Chief Medical Officer & Head of Development

Stefania Mazzoleni Ph.D.CTO

Director of Program Development

Barbara RegoniniCTO

Director of Finance

Richard B. SlanskyCFO

Chief Financial Officer

Pierluigi ParacchiCEO

Co-Founder, Chairman, Chief Executive Officer & GM

Luigi Naldini M.D., Ph.D.

Co-Founder & Chairman of the Executive Scientific Board

Bernard Rudolph Gentner M.D., Ph.D.

Co-Founder & Member of the Executive Scientific Board

Name

Position

Carlo Russo M.D.

Chief Medical Officer & Head of Development

Stefania Mazzoleni Ph.D.CTO

Director of Program Development

Barbara RegoniniCTO

Director of Finance

Richard B. SlanskyCFO

Chief Financial Officer

Pierluigi ParacchiCEO

Co-Founder, Chairman, Chief Executive Officer & GM

Luigi Naldini M.D., Ph.D.

Co-Founder & Chairman of the Executive Scientific Board

Bernard Rudolph Gentner M.D., Ph.D.

Co-Founder & Member of the Executive Scientific Board

Management Team

Carlo Russo M.D.

Chief Medical Officer & Head of Development

Stefania Mazzoleni Ph.D.CTO

Director of Program Development

Barbara RegoniniCTO

Director of Finance

Richard B. SlanskyCFO

Chief Financial Officer

Pierluigi ParacchiCEO

Co-Founder, Chairman, Chief Executive Officer & GM

Luigi Naldini M.D., Ph.D.

Co-Founder & Chairman of the Executive Scientific Board

Bernard Rudolph Gentner M.D., Ph.D.

Co-Founder & Member of the Executive Scientific Board

Management

Carlo Russo M.D.

Chief Medical Officer & Head of Development

Stefania Mazzoleni Ph.D.CTO

Director of Program Development

Barbara RegoniniCTO

Director of Finance

Richard B. SlanskyCFO

Chief Financial Officer

Pierluigi ParacchiCEO

Co-Founder, Chairman, Chief Executive Officer & GM

Luigi Naldini M.D., Ph.D.

Co-Founder & Chairman of the Executive Scientific Board

Bernard Rudolph Gentner M.D., Ph.D.

Co-Founder & Member of the Executive Scientific Board

Total 7 executives

GNTA Frequently asked questions

What is Genenta Science S.p.A. (GNTA) Stock Price?

Current stock price of Genenta Science S.p.A. (GNTA) stock is $0.980. The stock price is -3.16% lower in the session. The intraday range can be seen from this page. Volume of Genenta Science S.p.A. (GNTA) stock is 23.32K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Genenta Science S.p.A. (GNTA) stock price going up or down today?

The stock price of Genenta Science S.p.A. (GNTA) can change with earnings, company news, and overall market sentiment. Genenta Science S.p.A. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Genenta Science S.p.A. stock expensive at its current price?

Whether Genenta Science S.p.A. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GNTA on this page is -1.34. EPS on this page is -0.73. Compare those figures with peers and growth expectations before deciding if the current Genenta Science S.p.A. price is justified.

How has the stock price of Genenta Science S.p.A. (GNTA) performed historically?

Historical performance for Genenta Science S.p.A. (GNTA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GNTA reacted to past earnings and market events.

Should I buy Genenta Science S.p.A. (GNTA) stock, at this price?

Buying Genenta Science S.p.A. (GNTA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.